Arteriosclerosis
Not recruitingStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
- Disease:Arteriosclerosis
- Substances:Inclisiran
Spain- Participants:18–64 years · 65+ years
- Substances:Inclisiran
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to Spain150 clinical trials in Caceres, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
SpainThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on acute myeloid leukemia and related blood disorders, evaluating novel therapeutic combinations and treatment approaches.
Studies include investigations of eganelisib, RVU120, and other promising compounds for refractory conditions.
Innovative trials examining treatments for coronary artery disease and related cardiovascular conditions, including specialized therapies for arterial dissection.
Research includes evaluation of novel medications and therapeutic approaches for various cardiac conditions.
Comprehensive research in breast cancer and melanoma, investigating targeted therapies and combination treatments for various cancer types.
Multiple trials exploring innovative treatment approaches for both early-stage and advanced cancers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.